Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as Non-alcoholic fatty liver disease (NAFLD), is estimated to affect up to 1 in 5 people in the UK. Rates are increasing with rising levels of obesity. Although most cases of MASLD are linked to excess weight, you can develop the disease if you have a healthy weight. In this podcast, Dr Thomas Round talks to Dr Helen Jarvis, a GP and Clinical lecturer and researcher at Newcastle University with an interest in liver disease about fatty liver disease in primary care. RCGP. EKU Module on Diagnosis and management of non-alcoholic fatty liver disease . May 2024. RCGP. Liver Toolkit . June 2025 BSG. BSG Guidelines on the management of abnormal liver blood tests . December 2021. NICE. NG49. Non-alcoholic fatty liver disease (NAFLD): assessment and management . July 2016 (last reviewed October 2024).
